Cystourethroscopes

Welcome to Cystourethroscopes Site

Cystourethroscopes Resources

Home > Cystourethroscopes > Listen to The Lancet: 31 May

Listen to The Lancet: 31 May

In this week's podcast, editor Sally Hargreaves talks to the author of a Research Article published early online on sudden unexplained death in infants (SUDI). Although sudden infant death remains one of the most common presentations of post-neonatal infant death in the UK, there still remain numerous theories about its cause. Dr Neil Sebire from the Great Ormond Street Hospital for Children, London, UK, discusses with Sally key findings and implications of the study. Researchers found high levels of Staphylococcus aureus and Escherichia coli bacteria in post-mortem samples from unexplained cases of SUDI, suggesting that these bacteria could be associated with the condition.

Click Here to read the entire article...

Other Articles:

•

PTC Therapeutics Announces Data From Additional Clinical Studies Of PTC124 In Cystic Fibrosis Confirming Activity

PTC Therapeutics, Inc. (PTC) announced promising new data from two studies of PTC124 in cystic fibrosis (CF).

Click Here to read the entire article...

•

Fireworks

none

Click Here to read the entire article...

•

Zoom RhythmTrak RT-323

£25.00 (1 Bid)
End Date: Monday Jul-28-2008 15:16:40 BST
Bid now | Add to watch list

Click Here to read the entire article...

•

Medtech Startups, September 2007

New medical technologies represented in companies added (September 2007) to the Medtech Startups Database and/or added to the September 2007 issue of MedMarkets.

The following are brief technology descriptions for companies newly added to the MedMarket Diligence Medtech Startups Database and/or covered in MedMarkets Startups during the month of August.

Medical technology incubator.
Electromagnetic thermal therapy for treatment of pain and improved function in osteoarthritis.
Anti-thrombotic treatment of myocardial infarction.
Percutaneous repair of mitral valve.
Nanoparticle-based drug delivery for non-Hodgkin's lymphoma, others.
Drug and bioactive agent delivery.
Blood glucose monitoring via intraosseously implanted optoelectric sensor.
Image-guided stereotactice radiosurgery for breast cancer.
Microwave thermokeratoplasty for "non-incisive" refractive surgery in ophthalmology.
Electrode array for bloodless liver resection.
Device for creating multiple lesions using ablation for treatment of atrial fibrillation.
Nanotechnology-mediated gene therapy for treatment of congestive heart failure.
Fracture healing stimulated via Pulsed Electromagnetic Field Therapy (PEMF).
Image-guided cancer therapy using contrast enhanced MRI and photodynamic therapy.
Bioartificial bone and cartilage replacement.
Catheter device to size lumens in stent delivery.
Bone-targeting polymeric drug delivery systems.
Pulmonary drug/drug delivery based on particle technologies.
Device to improve pleural and pericardial drainage following heart surgery.

For coverage in specific issues of MedMarkets, see link.

For details on the Medtech Startups Database, see link.

Tags: medtech, startup

Click Here to read the entire article...

•

Soy Linked to Low Sperm Count (HealthDay)

HealthDay - WEDNESDAY, July 23 (HealthDay News) -- Eating half a serving of soy food a day lowers sperm concentrations and may play a role in male infertility, particularly in obese men, Harvard University researchers report.

Click Here to read the entire article...

•

[Medical_Sciences] Tropism-independent protection of macaques against vaginal transmission of three SHIVs by the HIV-1 fusion inhibitor T-1249

We have assessed the potential of the fusion inhibitory peptide T-1249 for development as a vaginal microbicide to prevent HIV-1...

Click Here to read the entire article...